Study of the Mechanism of Antiviral Activity of Cytovir®-3 Against Respiratory Viruses In Vitro
Антибиотики и Химиотерапия, 2023 Introduction. The requirements of modern clinical guidelines for the treatment of respiratory viral infections suggest the possibility of identifying a specific viral pathogen.
V. V. Zarubaev +6 more
doaj +1 more source
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
Infectious Disease and Therapy, 2021 Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults.
J. Domachowske +2 more
semanticscholar +1 more source
Human Vaccines & Immunotherapeutics, 2021 To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection ...
Natividad Viguria +5 more
doaj +1 more source
An update on respiratory syncytial virus
BMC Infectious Diseases, 2023 AbstractRespiratory syncytial virus (RSV) is a leading cause of acute respiratory infections resulting in a significant burden worldwide, particularly in children and older adults. This collection calls for original research papers that advance our understanding of the epidemiology, evolution, diagnosis, clinical management, and prevention of RSV ...
Antonio Piralla +2 more
openaire +3 more sources
RSV infection and recurrence of respiratory tract obstruction in children
Pediatria i Medycyna Rodzinna, 2016 Viruses, including the respiratory syncytial virus, are the most common aetiological factor of respiratory infections in children. The disease most often occurs between November and April in the northern climate zone, with a peak incidence in January ...
Karolina Kapusta +2 more
doaj +1 more source
Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults [PDF]
, 2022 Background. Respiratory syncytial virus (RSV) causes a substantial burden in older adults. Viral load in RSV-infected adults is generally lower compared to young children, which could result in suboptimal sensitivity of RSV diagnostics.
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
core
Viral etiology of acute respiratory infections in hospitalized children in Novosibirsk City, Russia (2013 - 2017). [PDF]
PLoS ONE, 2018 BACKGROUND:Acute respiratory infections (ARIs) cause a considerable morbidity and mortality worldwide especially in children. However, there are few studies of the etiological structure of ARIs in Russia. In this work, we analyzed the etiology of ARIs in
Olga Kurskaya +11 more
doaj +1 more source
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting [PDF]
, 2020 Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England.
Kinyanjui, Timothy +5 more
core +1 more source
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. [PDF]
, 2015 Respiratory syncytial virus (RSV) is a globally prevalent cause of lower respiratory infection in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has remained elusive.
Giersing, Birgitte +5 more
core +1 more source
Influenza and Other Respiratory Viruses, 2021 Respiratory syncytial virus (RSV) infections are one of the leading causes of lower respiratory tract infections and have a major burden on society. For prevention and control to be deployed effectively, an improved understanding of the seasonality of ...
Lisa Staadegaard +28 more
semanticscholar +1 more source